As Minister for Public Health & Innovation, Nicola marked World Cancer Day by visiting the Oxford Cancer Centre at the Churchill Hospital to highlight the importance of UK scientific research to beating cancer.
Nicola toured the facility to see the state-of-the-art clinical trails, National Institute for Health (NIHR) Biomedical Research-funded Centre and facilities for new cancer treatments and patients.
Increased Government investment, through the NIHR, has led to the largest ever funding in the UK for Biomedical Research Centres and dedicated Clinical Research Facilities in the NHS (amounting to over £920m last year). Oxford University Hospitals NHS Foundation Trust hosts the NIHR Oxford Biomedical Research Centre, a partnership between the Trust and the University of Oxford, to fund medical research and the BRC has enabled numerous scientific advances.
Particularly in cancer research, Oxford has made many contributions to understanding the use of genome sequencing in cancer diagnoses and in identifying the correct treatment for a patient’s individual cancer. This has also underpinned the cancer programme in Genomics England and enabled targeted trials of many new drugs for cancer.
Nicola met with Oxford’s BRC Director Keith Channon, discussing the wide range of cutting edge research in cancer, from new discoveries in genetics through to patients receiving world-first drugs in clinical trials.
Nicola says: I was blown away by the pioneering research and peronalised care at the Churchill; the UK is among the very best in the world for medical and health research, and Oxford has a proud tradition of being at the heart of our endeavour to push the boundaries of modern medicine. We want to ensure the best possible outcome from exiting the EU, and Oxford is clearly a key part of Britain’s post-Brexit scientific success.